Diag Capital Management’s Sanofi SNY Stock Holding History

Diag Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1.31M	Buy	+30,240	New	+$1.33M	1.5%	25

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Diag Capital Management's SNY Position: Q4 2018 in Review

Diag Capital Management opened a new position in Sanofi (SNY) in Q4 2018: 30,240 shares worth $1.31M. The stake represents 1.5% of the portfolio and ranks #25 among its holdings.

501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

Diag Capital Management held 30,240 shares of Sanofi worth $1.31M as of Q4 2018.
Sanofi was a new Diag Capital Management position in Q4 2018.
Sanofi made up 1.5% of Diag Capital Management's portfolio in Q4 2018, its #25 holding.
501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.